Proteostasis Therapeutics, Inc. Email Format

BiotechnologyMassachusetts, United States51-200 Employees

Proteostasis Therapeutics, Inc. operates in the biotechnology research industry as a clinical-stage company focused on small-molecule therapeutics designed to restore protein function in disorders caused by dysfunctional protein processing. Its work centers on cystic fibrosis and other conditions rooted in impaired protein processing, seeking to correct the underlying protein dysfunction rather than simply treating symptoms. The company is headquartered in Boston, Massachusetts, where its team pursues the discovery and development of therapies aimed at re-establishing normal protein activity.

As a mid-sized biopharma entity, Proteostasis occupies a position in the clinical development space that translates insights about protein handling into potential therapeutic candidates. Its target patients include individuals with cystic fibrosis and related protein-processing diseases. In August 2020, Proteostasis announced a merger with Yumanity Therapeutics, marking a notable corporate development for the company.

Get verified Proteostasis Therapeutics, Inc. emails free

Company overview Employee directory